Breakthroughs in Targeting KRAS G12C Mutations in NSCLC
Krithika Subramanian, PhDDr. Ziming Li and other panelists recently explored encouraging clinical trial data for novel therapies, including garsorasib, olomorasib, fulzerasib, and divarasib. Read more
Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients
Fred GebhartDuring the 2024 WCLC, Dr. Shalini Vinod reviewed data showing that a nurse-led care model for geriatric patients outperformed a medical-led model. Read more
Taletrectinib Shows Promising Results in Patients with ROS1-Positive NSCLC
Fred GebhartDr. Geoffrey Liu presented results from the TRUST-II trial on the safety and efficacy of taletrectinib in TKI-naive and TKI-pretreated patients. Read more
IASLC Communications Committee members gathered during a WCLC 2024 workshop to share tips on tailoring messages to different audiences, building a strong social media presence, and more. Read more
WCLC Closing Plenary Explored Overcoming Barriers to Patient Advocacy Worldwide
Haleigh BehrmanGlobal leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives. Read more
Dr. Yixian Crystal Chen recently presented results that demonstrate fine particulate matter poses health risks, even for those with no smoking history. Read more
Study Evaluating Tusamitamab Ravtansine in Patients with Non-Squamous NSCLC is Discontinued
Fred GebhartDr. Benjamin Besse recently discussed detailed findings from the now discontinued CARMEN-LC03 trial. Read more
LUMINOSITY Subgroup Analysis Shows Similar Results for Asian Patients Compared to Global Population
Fred GebhartDr. Hidehito Horinouchi said treatment with Teliso-V demonstrated promising and durable responses in Asian cohort, particularly those with high c-Met expression. Read more
TROPION-Lung01 Demonstrates Improvement in PFS; OS Improvement Fails to Reach Statistical Significance
Fred GebhartDr. Jacob Sands presented findings that show a progression-free survival advantage for Dato-DXd versus docetaxel in the non-squamous cohort. Read more
Climate Change, Pollution, War, and More Increasing Risk, Impacting Management of Lung Cancer Worldwide
Haleigh BehrmanDr. Leticia Nogueira and other experts explored non-tobacco factors that are playing a role in our evolving knowledge during a WCLC 24 plenary session. Read more